Shiraishi et al (41) studied the different locations of TP53 mutations between anaplastic astrocytoma and GBM, and suggested that the TP53 mutation may contribute to tumorigenesis and also to the progression of malignancy in gliomas. Here, TP53 is linked to central nervous system cancer.